Intended for healthcare professionals

Rapid response to:

Letters Generic drug pricing

The scandal of generic drug pricing: drug regulation policies need review

BMJ 2017; 356 doi: https://doi.org/10.1136/bmj.j947 (Published 23 February 2017) Cite this as: BMJ 2017;356:j947

Rapid Response:

Re: The scandal of generic drug pricing: drug regulation policies need review

Despite ongoing recession and implementation of strict austerity measures, prices of generics in Greece are still high, sometimes up to 880% higher than the same generics in Sweden! [1]
Even so, generics in Greece are prescribed only in 20% of patients. [2][3]
References
[1] http://neoskosmos.com/news/en/generic-drug-prices-sky-high
[2] http://gabi-journal.net/news/measures-to-increase-generics-use-in-greece
[3] https://www.ihs.com/country-industry-forecasting.html?ID=10659107152

Competing interests: No competing interests

03 March 2017
Stavros Saripanidis
Consultant in Obstetrics and Gynaecology
Thessaloniki, Greece